Bio-Rad Laboratories, Inc. (FRA:BUW)

Market Cap	6.75B -27.4%
Revenue (ttm)	2.18B -0.9%
Net Income	-576.07M
EPS	-20.93
Shares Out	n/a
PE Ratio	n/a
Forward PE	29.11
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	224.00
Previous Close	224.00
Day's Range	224.00 - 224.00
52-Week Range	206.00 - 332.00
Beta	n/a
RSI	33.71
Earnings Date	Feb 12, 2026

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science e...

• Industry: Laboratory Analytical Instruments
• Founded: 1952
• Employees: 7,700
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BUW

Financial Performance

In 2024, Bio-Rad Laboratories's revenue was $2.57 billion, a decrease of -3.92% compared to the previous year's $2.67 billion. Losses were -$1.84 billion, 189.4% more than in 2023.

Financial numbers in USD